发明名称 |
Ocular diagnosis of Alzheimer's Disease |
摘要 |
The invention features a method of diagnosing or providing a prognosis regarding the state of Alzheimer's Disease in a mammal by contacting an ocular tissue with a detectably-labeled compound, which binds to an amyloid protein. An increase in binding of the compound to the ocular tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.
|
申请公布号 |
US6849249(B2) |
申请公布日期 |
2005.02.01 |
申请号 |
US20020132779 |
申请日期 |
2002.04.25 |
申请人 |
THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;THE GENERAL HOSPITAL CORPORATION |
发明人 |
GOLDSTEIN LEE E.;CHYLACK, JR. LEO T. |
分类号 |
G01N33/50;A61K49/00;G01N33/15;G01N33/53;G01N33/566;(IPC1-7):A61K49/00 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|